Filter
750
Text search:
TB
Treatment
outcomes
Featured
Recommendations
72
New Publications
192
Language
Document type
No document type
481
Studies & Reports
108
Guidelines
74
Strategic & Response Plan
33
Manuals
19
Fact sheets
14
Training Material
10
Situation Updates
5
Resource Platforms
4
Infographics
2
Countries / Regions
Kenya
31
South Africa
31
India
25
Western and Central Europe
22
Malawi
21
Global
21
Tanzania
18
Eastern Europe
17
Rwanda
16
Namibia
15
Sierra Leone
14
Ethiopia
14
Uganda
13
Zambia
13
Ghana
12
Nepal
12
Africa
12
Liberia
10
Myanmar / Burma
8
Latin America and the Carribbean
8
Nigeria
7
Bangladesh
7
Ukraine
7
Lesotho
7
Cambodia
6
Asia
6
Russia
6
Zimbabwe
5
Philippines
5
South–East Asia Region
5
Mozambique
4
Botswana
4
Senegal
3
Syria
3
Benin
3
Tajikistan
3
Cameroon
2
Pakistan
2
South Sudan
2
Germany
2
Argentina
2
Colombia
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Georgia
2
Guinea
1
Congo, Democratic Republic of
1
Guinea-Bissau
1
USA
1
Jordan
1
Afghanistan
1
Lebanon
1
Indonesia
1
Papua New Guinea
1
Sudan
1
Peru
1
Angola
1
Sri Lanka
1
Yemen
1
Bhutan
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Estonia
1
Iran
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
306
Clinical Guidelines
64
Public Health
26
Key Resources
19
Women & Child Health
16
Pharmacy & Technologies
6
Capacity Building
5
Toolboxes
TB
170
HIV
116
AMR
30
COVID-19
30
Mental Health
24
Caregiver
18
NCDs
13
NTDs
11
Global Health Education
10
Ebola & Marburg
8
Pharmacy
8
Disability
7
Polio
7
Conflict
6
Refugee
6
Natural Hazards
4
Planetary Health
4
Health Financing Toolbox
4
Zika
2
Cholera
1
Rapid Response
1
Specific Hazards
1
Social Ethics
1
The Anglophone Africa Civil Society and Communities CCM Shadow Report and Scorecard Initiative
Afr J Psychiatry 2011;14:200-207
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
J Nepal Health Res Counc 2013 May;11(24):198-204
Accessed: 26.09.2019
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Primary Care: The Community Health System
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
This clinical job aid addresses the importance of maternal health and antiretroviral therapy adherence, as well as care and testing for the HIV-exposed infant until the infant’s final HIV diagnosis after the end of breastfeeding.
HOW ICAP IS BUILDING NURSING AND MIDWIFERY CAPACITY AND STRENGTHENING HEALTH SYSTEMS